A comprehensive review. J Clin Pharm Ther 2001; 26: 331–342. 6  Horne R, Buick D, Fisher M et al. Doubts about necessity and concerns about adverse effects: identifying the types of beliefs that are associated ERK inhibitor with non-adherence to HAART. Int J STD AIDS 2004; 15: 38–44. 7  Horne R, Cooper V, Gellaitry G et al. Patients’ perceptions of highly active antiretroviral therapy in relation to treatment uptake and adherence: the utility of the necessity-concerns framework. J Acquir Immune Defic Syndr 2007; 45: 334–341. 8  Gonzalez JS, Penedo FJ, Llabre MM et al. Physical symptoms, beliefs about medications,

negative mood, and long-term HIV medication adherence. Ann Behav Med 2007; 34: 46–55. 9  Maasoumy B, Manns MP. Optimal treatment with boceprevir for chronic HCV infection. Liver Int 2013; 33(Suppl 1): 14–22. 10  Gonzalez JS, Batchelder AW, Psaros C et al. Depression and HIV treatment non-adherence: a review and meta-analysis. J Acquir Immune Defic Syndr 2011; 58: 181–187. 11  Hendershot CS, Stoner SA, Pantalone DW et al. Alcohol use and antiretroviral adherence: review and meta-analysis. J Acquir Immune Defic Syndr 2009; 52: 180–202. 12  Reback CJ, Larkins S, Shoptaw S. Methamphetamine Forskolin manufacturer abuse as a barrier to HIV medication adherence among gay and bisexual men. AIDS Care 2003; 15: 775–785.

13  Halkitis PN, Kutnick AH, Borkowski T et al. Adherence to HIV medications and club drug use among gay and bisexual men. XIV International AIDS Conference. Barcelona, Spain. July 2002 [Abstract ThPeE7856]. 14  Lima VD, Geller J, Bangsberg DR et al. The effect of adherence on the association between depressive symptoms and mortality among HIV-infected individuals first initiating HAART. AIDS 2007; 21: 1175–1183. 15  Yun LW,

Maravi M, Kobayashi JS et al. Antidepressant treatment improves adherence to antiretroviral therapy among depressed HIV-infected patients. J Acquir Immune Defic Syndr 2005; 38: 432–438. 16  Arroll B, Khin N, Kerse N. Screening for Cyclooxygenase (COX) depression in primary care with two verbally asked questions: cross sectional study. BMJ 2003; 327: 1144–1146. 17  Holzemer WL, Corless IB, Nokes KM et al. Predictors of self-reported adherence in persons living with HIV disease. AIDS Patient Care STDS 1999; 13: 185–197. 18  Smith SR, Rublein JC, Marcus C et al. A medication self-management program to improve adherence to HIV therapy regimens. Patient Educ Couns 2003; 50: 187–199. 19  Gifford AL, Laurent DD, Gonzales VM et al. Pilot randomized trial of education to improve self-management skills of men with symptomatic HIV/AIDS. J Acquir Immune Defic Syndr 1998; 18: 136–144. 20  Lorig KR, Sobel DS, Stewart AL et al. Evidence suggesting that a chronic disease self-management program can improve health status while reducing hospitalization: a randomized trial. Med Care 1999; 37: 5–14. 21  British Psychological Society, British HIV Association, Medical Foundation for AIDS and Sexual Health.